AMERIPRISE FINANCIAL INC - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 133 filers reported holding ANIKA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,555,278
-40.1%
244,513
-16.4%
0.00%
-50.0%
Q2 2023$7,600,838
+27.1%
292,565
+40.5%
0.00%0.0%
Q1 2023$5,979,531
+11.1%
208,201
+14.4%
0.00%0.0%
Q4 2022$5,384,000
+18.2%
181,943
-4.9%
0.00%0.0%
Q3 2022$4,555,000
-4.2%
191,360
-10.1%
0.00%0.0%
Q2 2022$4,753,000
-13.1%
212,953
-2.3%
0.00%0.0%
Q1 2022$5,472,000
-84.5%
217,881
-77.9%
0.00%
-80.0%
Q4 2021$35,385,000
-16.4%
987,648
-0.7%
0.01%
-28.6%
Q3 2021$42,344,000
-1.9%
994,957
-0.2%
0.01%
+7.7%
Q2 2021$43,167,000
+6.1%
997,172
-0.0%
0.01%
-7.1%
Q1 2021$40,681,000
-10.5%
997,355
-0.7%
0.01%
-12.5%
Q4 2020$45,445,000
+27.5%
1,004,108
-0.3%
0.02%
+14.3%
Q3 2020$35,636,000
+3.4%
1,006,939
+10.2%
0.01%
-6.7%
Q2 2020$34,461,000
+85.0%
913,365
+41.8%
0.02%
+50.0%
Q1 2020$18,626,000
-37.8%
644,291
+11.5%
0.01%
-16.7%
Q4 2019$29,964,000
-15.4%
577,888
-10.5%
0.01%
-25.0%
Q3 2019$35,437,000
-12.9%
645,583
-35.5%
0.02%
-11.1%
Q2 2019$40,664,000
+108.7%
1,001,079
+55.4%
0.02%
+100.0%
Q1 2019$19,486,000
+182.0%
644,393
+213.5%
0.01%
+200.0%
Q4 2018$6,909,000
-18.4%
205,544
+2.3%
0.00%0.0%
Q3 2018$8,471,000
+33.4%
200,837
+1.2%
0.00%0.0%
Q2 2018$6,350,000
-63.0%
198,436
-42.4%
0.00%
-62.5%
Q1 2018$17,141,000
+172.9%
344,747
+195.9%
0.01%
+166.7%
Q4 2017$6,280,000
-9.2%
116,494
-2.3%
0.00%0.0%
Q3 2017$6,914,000
+10.5%
119,209
-6.0%
0.00%0.0%
Q2 2017$6,257,000
+21.6%
126,803
+7.0%
0.00%0.0%
Q1 2017$5,146,000
+14.2%
118,456
+28.6%
0.00%
+50.0%
Q4 2016$4,508,000
+28.9%
92,094
+26.0%
0.00%0.0%
Q3 2016$3,497,000
-10.2%
73,085
+0.7%
0.00%0.0%
Q2 2016$3,893,000
-2.8%
72,560
-19.0%
0.00%0.0%
Q1 2016$4,007,000
+55.4%
89,583
+32.6%
0.00%0.0%
Q4 2015$2,578,000
+16.3%
67,575
-2.9%
0.00%
+100.0%
Q3 2015$2,216,000
-4.1%
69,628
-0.5%
0.00%0.0%
Q2 2015$2,311,000
-20.3%
69,995
-0.6%
0.00%
-50.0%
Q1 2015$2,898,000
+8.2%
70,390
+7.1%
0.00%0.0%
Q4 2014$2,678,000
-10.2%
65,724
-19.2%
0.00%0.0%
Q3 2014$2,982,000
-2.7%
81,335
+22.9%
0.00%0.0%
Q2 2014$3,065,000
+58.1%
66,165
+40.2%
0.00%
+100.0%
Q1 2014$1,939,000
+13.3%
47,182
+5.2%
0.00%0.0%
Q4 2013$1,712,000
+9411.1%
44,843
+5887.0%
0.00%
Q3 2013$18,000
-85.7%
749
-89.8%
0.00%
Q2 2013$126,0007,3390.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Caligan Partners LP 1,081,360$20,145,7379.25%
Trigran Investments, Inc. 2,217,019$41,303,0654.40%
DIKER MANAGEMENT LLC 50,239$935,9530.84%
Virtus Investment Advisers, Inc. 45,579$849,1370.58%
Virtus Fund Advisers, LLC 3,490$65,0190.46%
CAPITAL MANAGEMENT CORP /VA 84,225$1,569,1120.35%
Riverwater Partners LLC 17,597$327,8320.30%
BOOTHBAY FUND MANAGEMENT, LLC 617,602$11,505,9250.27%
XTX Topco Ltd 28,033$522,2550.09%
GSA CAPITAL PARTNERS LLP 51,638$9620.08%
View complete list of ANIKA THERAPEUTICS INC shareholders